FindTrial
Sign In

Nucleated red blood cells as a novel biomarker in the prediction of acute kidney injury and prognosis in acute pancreatitis: a retrospective study

Nucleated red blood cells as a novel biomarker in the prediction of acute kidney injury and prognosis in acute pancreatitis: a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090774
Enrollment
Unknown
Registered
2024-10-12
Start date
2024-10-16
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pancreatitis

Interventions

NRBC positive group and NRBC negative group:NA

Sponsors

the Second Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: The clinical and laboratory data of AP patients admitted to our hospital between January 2020 and January 2024 was collected and analyzed in this study.

Exclusion criteria

Exclusion criteria: (1) less than 18 years old; (2) during pregnancy; (3)previous afflicted with blood disorders, including blood tumors and other blood disorders; (4) suffering from chronic kidney disease, renal parenchymal or interstitial injury due to factors other than pancreatitis or, a history of renal transplantation; (5)incomplete or missing medical records; or (6) death or discharge within 7 days of admission.

Design outcomes

Primary

MeasureTime frame
Nucleated red blood cells ;—

Countries

China

Contacts

Public ContactHualan Huang

the Second Xiangya Hospital, Central South University

huanghualan2012@163.com+86 731 8529 2033

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026